NDC 55379-405-30 - Hybrisil
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55379-405
- Requested NDC
- 55379-405-30
- Package NDCs from labels
- 55379-405-30, 55379-405-31
- Manufacturer
- BioZone Laboratories, Inc.
- Effective date
- 2011-04-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hybrisil - BioZone Laboratories, Inc. | BioZone Laboratories, Inc. | 2011-04-22 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 55379-405-31 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-c55d-8e05-e053-dbdaa90a074a | f8432414-d8a6-4597-a226-61fd09a80e0c |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55379-405-30 | Hybrisil | 30 g in 1 BOTTLE, PUMP | GEL | 30 | 2 | |
| 55379-405-31 | Hybrisil | 1 in 1 CARTON | GEL | 1 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Methylprednisolone Acetate | ACTIVE INGREDIENT | 43502P7F0P | HYBRISIL (METHYLPREDNISOLONE ACETATE) GEL [BIOZONE LABORATORIES, INC.] | 2 | |
| Methylprednisolone | ACTIVE MOIETY | X4W7ZR7023 | HYBRISIL (METHYLPREDNISOLONE ACETATE) GEL [BIOZONE LABORATORIES, INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Depo-Medrol | METHYLPREDNISOLONE ACETATE | Asclemed USA, Inc. | cb0e1c92-d2df-47f8-ab3f-edc1a98bf4b6 | 2022-10-12 | Warnings, Adverse reactions | 43502P7F0P |
| 4e2e9bc4-6ba8-11e0-ae3e-0800200c9a66 | f8432414-d8a6-4597-a226-61fd09a80e0c | 2011-04-22 | Warnings, Adverse reactions | 4e2e9bc4-6ba8-11e0-ae3e-0800200c9a66 f8432414-d8a6-4597-a226-61fd09a80e0c |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.